EZZ Life Science Holdings Dividends and Buybacks
Dividend criteria checks 3/6
EZZ Life Science Holdings is a dividend paying company with a current yield of 2.58% that is well covered by earnings. Next payment date is on 23rd December, 2025 with an ex-dividend date of 24th November, 2025.
Key information
2.6%
Dividend yield
-0.6%
Buyback Yield
| Total Shareholder Yield | 2.0% |
| Future Dividend Yield | 3.4% |
| Dividend Growth | 40.3% |
| Next dividend pay date | 23 Dec 25 |
| Ex dividend date | 24 Nov 25 |
| Dividend per share | n/a |
| Payout ratio | 6% |
Recent dividend and buyback updates
Recent updates
Even With A 52% Surge, Cautious Investors Are Not Rewarding EZZ Life Science Holdings Limited's (ASX:EZZ) Performance Completely
Oct 28
EZZ Life Science Holdings' (ASX:EZZ) Earnings Quality Is Low
Sep 05With EPS Growth And More, EZZ Life Science Holdings (ASX:EZZ) Makes An Interesting Case
Aug 07EZZ Life Science Holdings Limited (ASX:EZZ) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Jun 16
US Rebranding And New Product Launches Will Broaden Global Reach
Expansion into the US and new product launches are set to drive significant revenue growth and enhance market share.Earnings Working Against EZZ Life Science Holdings Limited's (ASX:EZZ) Share Price Following 25% Dive
Mar 27Does EZZ Life Science Holdings (ASX:EZZ) Deserve A Spot On Your Watchlist?
Feb 26Why Investors Shouldn't Be Surprised By EZZ Life Science Holdings Limited's (ASX:EZZ) 27% Share Price Surge
Jan 01EZZ Life Science Holdings Limited (ASX:EZZ) May Have Run Too Fast Too Soon With Recent 25% Price Plummet
Nov 04EZZ Life Science Holdings Limited's (ASX:EZZ) Shares Leap 41% Yet They're Still Not Telling The Full Story
Aug 28EZZ Life Science Holdings Limited (ASX:EZZ) Stock Catapults 29% Though Its Price And Business Still Lag The Market
Jun 05There's No Escaping EZZ Life Science Holdings Limited's (ASX:EZZ) Muted Earnings Despite A 28% Share Price Rise
Apr 02Here's Why We Think EZZ Life Science Holdings (ASX:EZZ) Is Well Worth Watching
Feb 09EZZ Life Science Holdings Limited's (ASX:EZZ) Share Price Is Matching Sentiment Around Its Earnings
Oct 18EZZ Life Science Holdings' (ASX:EZZ) Promising Earnings May Rest On Soft Foundations
Mar 06Calculating The Fair Value Of EZZ Life Science Holdings Limited (ASX:EZZ)
Nov 22Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, EZZ has been paying a dividend for less than 10 years.
Growing Dividend: EZZ's dividend payments have increased, but the company has only paid a dividend for 4 years.
Dividend Yield vs Market
| EZZ Life Science Holdings Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (EZZ) | 2.6% |
| Market Bottom 25% (AU) | 2.4% |
| Market Top 25% (AU) | 5.6% |
| Industry Average (Personal Products) | 2.4% |
| Analyst forecast (EZZ) (up to 3 years) | 3.4% |
Notable Dividend: EZZ's dividend (2.58%) is higher than the bottom 25% of dividend payers in the Australian market (2.43%).
High Dividend: EZZ's dividend (2.58%) is low compared to the top 25% of dividend payers in the Australian market (5.62%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (5.7%), EZZ's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (45.9%), EZZ's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/04 07:29 |
| End of Day Share Price | 2025/12/04 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
EZZ Life Science Holdings Limited is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Lodge Partners Pty Ltd. |
| Chris Kallos | MST Financial Services Pty Limited |